Evidence mapPaperPMID 31480425Full record

ArticleMedical sciences (Basel, Switzerland)2019

Diuretic Activity of a Novel Peripherally-Restricted Orally-Active Kappa Opioid Receptor Agonist.

Tyler C Beck, Matthew A Hapstack, Gautam S Ghatnekar, Thomas A Dix

Open access · goldAbstract read
In one paragraph

Article in Medical sciences (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Tyler C BeckDrug Discovery & Biomedical Sciences, Medical University of South Carolina, 280 Calhoun Street, QF204, Charleston, SC 29424-2303, USA. beckt@musc.edu.ORCID 0000-0002-1717-8943
Matthew A HapstackCollege of Medicine, Medical University of South Carolina, 173 Ashley Ave., Charleston, SC 29424-2303, USA.
Gautam S GhatnekarDrug Discovery & Biomedical Sciences, Medical University of South Carolina, 280 Calhoun Street, QF204, Charleston, SC 29424-2303, USA.
Thomas A DixDrug Discovery & Biomedical Sciences, Medical University of South Carolina, 280 Calhoun Street, QF204, Charleston, SC 29424-2303, USA. dixta@musc.edu.ORCID 0000-0001-9387-1689
Medical University of South Carolina · US

Funding

Novel Neurotensin Analogs as AntischizophrenicsR44MH065099 · ARGOLYN BIOSCIENCE, INC. · 2005 to 2005
$476k
Novel Neurotensin Analogs as AntischizoprenicsR41MH065099 · ARGOLYN BIOSCIENCE, INC. · 2002 to 2002
$139k
National Heart and Lung Institute HL007260NIDA NIH HHS DA-036398NIMH NIH HHS MH-65099NINDS NIH HHS NS-090629
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

agonistcardiovascular diseasediureticheart failurekappaopioid

Identifiers

PMID31480425
PMCPMC6780874
OpenAlexW2971100953

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.